Overview
Five years ago, the choice was simple: if you wanted ketamine therapy, you went to a clinic. Today, a growing number of telehealth companies offer ketamine treatment programs that allow patients to receive care from home, managed remotely by prescribing clinicians via video consultation. This expansion has made ketamine therapy accessible to far more people — but it has also raised important questions about how the two models compare in terms of safety, effectiveness, and quality of care.
This comparison breaks down the meaningful differences so you can make an informed choice based on your specific needs. For a deeper look at the telehealth model, see our telehealth ketamine guide.
How Each Model Works
Telehealth Ketamine Programs
You begin with a video consultation with a prescribing provider (typically a psychiatrist, nurse practitioner, or physician assistant) who evaluates your medical history, psychiatric history, current medications, and treatment goals. If approved, sublingual ketamine (troches or tablets) is shipped to your home from a licensed compounding pharmacy.
You self-administer the medication at home during scheduled sessions. Depending on the program, supervision during sessions may include a real-time video check-in, a phone call, or a post-session check-in. Regular follow-up appointments occur via video to assess your response and adjust treatment. Many programs require a treatment companion to be present during sessions.
In-Person Clinic Treatment
You visit a specialized ketamine clinic for an in-person evaluation. Treatment is administered on-site — most commonly as an IV infusion, intramuscular injection, or Spravato nasal spray. A clinical team monitors your vital signs throughout the session, and you remain at the clinic until you have recovered sufficiently to leave (with arranged transportation). Follow-up appointments and maintenance sessions occur at the same facility.
Routes of Administration
This is one of the most clinically significant differences between the two models:
| Route | Telehealth | In-Clinic | Bioavailability |
|---|---|---|---|
| IV infusion | Not available | Available | ~100% |
| IM injection | Not available | Available | ~93% |
| Sublingual | Primary route | Sometimes available | 25–35% |
| Spravato nasal spray | Not available | Available (certified facilities) | ~48% |
Telehealth programs are limited to sublingual (and occasionally oral) ketamine because these are the only forms that can be safely self-administered at home. In-clinic treatment offers access to the full range of administration routes, including the higher-bioavailability options that produce more consistent therapeutic plasma levels.
Effectiveness
Telehealth Programs
The lower bioavailability of sublingual ketamine means that doses must be adjusted to compensate, and plasma levels may be less consistent than with IV administration. However, real-world outcomes data from telehealth ketamine programs shows that many patients achieve meaningful symptom improvement. The convenience and affordability of telehealth programs also contribute to better adherence — patients are more likely to complete their full treatment course when logistical barriers are minimized.
In-Clinic Treatment
IV ketamine has the most extensive clinical evidence base and the most predictable pharmacokinetic profile. The controlled clinical environment ensures optimal conditions for treatment delivery. For patients with severe or treatment-resistant conditions, the higher bioavailability and clinical oversight of in-clinic treatment may produce more reliable results.
Safety Comparison
Telehealth Programs
Safety in telehealth programs relies on three pillars: thorough upfront screening, appropriate patient selection, and clear emergency protocols. Because a clinician is not physically present during the session, the screening process must be rigorous enough to identify and exclude patients with cardiovascular risk factors, psychotic disorder history, or other contraindications that would make unsupervised treatment inappropriate.
Quality telehealth programs mitigate risk by:
- Requiring detailed medical history and medication review
- Declining patients with significant risk factors
- Requiring a treatment companion during sessions
- Providing emergency contact information and protocols
- Starting at lower doses and titrating carefully
- Conducting regular follow-up assessments
In-Clinic Treatment
In-clinic treatment provides the highest level of safety for ketamine therapy. Continuous vital sign monitoring, immediate access to emergency medications and equipment, and the physical presence of trained medical staff create a safety net that telehealth programs cannot fully replicate. This makes in-clinic treatment the more appropriate choice for patients with:
- Cardiovascular concerns (history of hypertension, heart disease)
- Complex medication regimens with interaction potential
- History of severe adverse reactions to medications
- Significant psychiatric complexity
Cost Comparison
| Cost Factor | Telehealth | In-Clinic |
|---|---|---|
| Initial evaluation | $0–$250 | $150–$400 |
| Monthly treatment | $150–$400 | $1,600–$3,200 (IV, 2x/month) |
| Initial 6-week course | $300–$800 | $2,400–$4,800 |
| Annual maintenance | $1,800–$4,800 | $4,800–$14,000+ |
| Insurance coverage | Rarely covered | Rarely covered (except Spravato) |
The cost differential is the most dramatic practical difference between the two models. Telehealth ketamine programs typically cost 70 to 85 percent less than in-clinic IV infusions on an annual basis. For many patients, this difference determines whether treatment is financially feasible.
Convenience and Accessibility
Telehealth Programs
- No travel required — treatment from your own home
- Flexible scheduling — sessions on your own timeline
- Available regardless of proximity to a ketamine clinic
- Minimal disruption to work and family responsibilities
- Medication delivered to your door
In-Clinic Treatment
- Requires travel to a specialized facility (may be hours away for rural patients)
- Sessions scheduled during clinic hours
- Each visit requires several hours (travel, treatment, recovery)
- Transportation must be arranged for every session
- Time off work may be needed
For patients in metropolitan areas with multiple clinic options and flexible schedules, in-clinic treatment is logistically manageable. For patients in rural areas, those with limited transportation, or those with demanding schedules, telehealth may be the only viable pathway to treatment.
The Patient Experience
Telehealth
Being in your own home offers comfort, privacy, and familiarity. You can set up your environment exactly how you want it — your own music, lighting, blankets, and bed or chair. Some patients find that this personal environment produces a more relaxed and introspective experience. However, you are also responsible for managing your own space, which requires some preparation and discipline.
In-Clinic
The clinical environment provides structure and a clear separation between treatment and daily life. Some patients appreciate having a dedicated space for their sessions, with staff handling the logistics. The medical setting can feel reassuring — knowing that trained professionals are right there if you need them. On the other hand, some patients find clinical settings impersonal or anxiety-provoking.
Making Your Decision
Choose telehealth if:
- Cost is a primary concern
- You do not have a ketamine clinic nearby
- You are a straightforward candidate without significant medical complexity
- You value convenience and flexibility
- You have a reliable treatment companion available
Choose in-clinic if:
- You have cardiovascular concerns or complex medical history
- You want the highest bioavailability route (IV)
- You prefer direct medical supervision during treatment
- You have severe symptoms that warrant the most evidence-backed approach
- You can access a reputable clinic and manage the cost
Consider a hybrid approach:
Some patients start with in-clinic infusions for the initial treatment series, then transition to telehealth sublingual programs for more affordable long-term maintenance. Our choosing a ketamine clinic guide can help you evaluate in-person providers if you decide to start with clinic-based treatment.
References
- Greenway KT, et al. Ketamine pharmacokinetics by route of administration: a narrative review. Canadian Journal of Anesthesia, 2021. — Comparative pharmacokinetics across ketamine administration routes
- Hull TD, et al. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression. Journal of Clinical Psychiatry, 2022. — Real-world evidence supporting telehealth ketamine programs
- McIntyre RS, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression. American Journal of Psychiatry, 2021. — Evidence synthesis covering multiple administration routes
- Telehealth for mental health treatment. National Institute of Mental Health (NIMH). — Federal guidance on telehealth mental health services
- Bahji A, et al. Comparative efficacy of racemic ketamine and esketamine for depression. Journal of Affective Disorders, 2021. — Comparative efficacy data informing treatment selection
Verdict
In-clinic treatment provides superior medical supervision, higher bioavailability routes (IV and IM), and a controlled therapeutic environment, making it the preferred choice for patients with complex medical needs or severe symptoms. Telehealth programs dramatically expand access through lower costs, geographic reach, and scheduling flexibility, making ketamine therapy realistic for millions of patients who would otherwise go untreated. Both are legitimate treatment pathways when delivered by qualified providers with proper screening protocols.